Takumi Kawaguchi

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

Takumi Kawaguchi, Takafumi Yoshida, Masaru Harada et al. · American Journal Of Pathology · 2004 · 536 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +8

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

MAFLD identifies patients with significant hepatic fibrosis better than NAFLD

Sakura Yamamura, Mohammed Eslam, Takumi Kawaguchi et al. · Liver International · 2020 · 409 citations · Full text

Medicine, Internal Medicine, Pathology +17

Mechanism for Fatty Acid “Sparing” Effect on Glucose-induced Transcription

Takumi Kawaguchi, Kiyoshi Osatomi, Hiromi Yamashita et al. · Journal of Biological Chemistry · 2002 · 408 citations · Full text

Life Sciences, Biochemistry, Nutritional Sciences +17

Expression of Cyclooxygenase–2 in Human Hepatocellular Carcinoma: Relevance to Tumor Dedifferentiation

Hironori Koga, Shotaro Sakisaka, Masahito Ohishi et al. · Hepatology · 1999 · 401 citations · Full text

Medicine, Cancer Biology, Oncology +13